FIELD: medicine. SUBSTANCE: this method prescribes placing microquantity of blood admixed with coagulant in hypotonic medium (0.42 % NaCl in phosphate buffer solution having pH value of 7.0 to 7.4) containing 1,5 - 4,5 · 10-4 М alpha- or beta-blockers, standing the whole during 10 to 40 min, isolating nonhemolyzed erythrocytes by centrifuging, subjecting supernatants of test and pilot samples to spectrophometry at 540 nm, and then diagnosing hyperadrenergic form of hypertension if extinction ratio between pilot and test samples (level of alpha- and beta-adrenoreception of membranes) proves greater than 16 %. EFFECT: higher accuracy of diagnosis. 1 dwg, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR TREATMENT OF HYPERTENSIVE DISEASE OF II STAGE | 1993 |
|
RU2065744C1 |
| METHOD OF ESTIMATING α- AND β-ADRENOREACTIVITY OF HUMAN ERYTHROCYTES FROM CHANGE IN OSMOTIC RESISTANCE THEREOF UNDER EFFECT OF ADRENALIN AND ADRENERGIC BLOCKERS | 2011 |
|
RU2493565C2 |
| METHOD FOR EVALUATING EFFICIENCY OF β-ADRENOBLOCKERS AT ARTERIAL HYPERTENSION | 2002 |
|
RU2237246C2 |
| METHOD FOR PREDICTING PHARMACOTHERAPY ACTION WHEN APPLIED TO PATIENTS SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASES | 2001 |
|
RU2191381C1 |
| METHOD FOR PREDICTING THE PROGRESSION OF CHRONIC CARDIAC FAILURE WITHIN A YEAR AFTER A PREVIOUS MYOCARDIAL INFARCTION | 2019 |
|
RU2716749C1 |
| METHOD FOR PREDICTING THE TYPE OF PARTURITION ABNORMALITIES | 2005 |
|
RU2296993C2 |
| METHOD FOR PREDICTION OF ENDOTHELIAL FUNCTION CONDITION IN ANTIHYPERTENSIVE THERAPY | 2009 |
|
RU2406436C1 |
| METHOD FOR DETERMINING INDIVIDUAL SENSITIVITY TO BETA-ADRENOCEPTOR BLOCKERS IN ARTERIAL HYPERTENSION CASES | 2003 |
|
RU2265846C2 |
| METHOD FOR PREDICTING THE LONG-TERM ANTIHYPERTENSIVE EFFICACY OF RENAL DENERVATION IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION | 2021 |
|
RU2767134C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING GASTRIC TACHYCARDIA IN PATIENTS WITH CORONARY HEART DISEASE | 2021 |
|
RU2752362C1 |
